Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation.

Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation.

Item
http://www.wikidata.org/entity/Q40150731
Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC InhibitionCancer chemoprevention with dietary isothiocyanates mature for clinical translational researchMolecular targets of isothiocyanates in cancer: recent advancesSulforaphane attenuates EGFR signaling in NSCLC cellsCastanea sativa Mill. bark extract exhibits chemopreventive properties triggering extrinsic apoptotic pathway in Jurkat cells.Discovery and development of sulforaphane as a cancer chemopreventive phytochemical.Sulforaphane inhibits proliferation and invasive activity of everolimus-resistant kidney cancer cells in vitro.Natural sulforaphane as a functional chemopreventive agent: including a review of isolation, purification and analysis methods.Exploring the effects of isothiocyanates on chemotherapeutic drugs.
P2860

Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation.

Item
http://www.wikidata.org/entity/Q40150731
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Combination of doxorubicin and ...... lasts with p53Ser220 mutation.
@en
type
label
Combination of doxorubicin and ...... lasts with p53Ser220 mutation.
@en
prefLabel
Combination of doxorubicin and ...... lasts with p53Ser220 mutation.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P698
P356
P1433
P1476
Combination of doxorubicin and ...... lasts with p53Ser220 mutation.
@en
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P698